Japan Intellectual Property Rights: METHOD FOR SUPPRESSING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION

Japan, Feb. 27 -- TOYOBO CO LTD,INSTITUTE OF PHYSICAL & CHEMICAL RESEARCH has got intellectual property rights for 'METHOD FOR SUPPRESSING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION.' Other related details are as follows: Application Number: JP,2019-176436 Category (FI): C12Q1/6876@Z,C12N15/09@Z,C12Q1/6844@Z,C12N9/22,C12N9/12 Stage: PROBLEM TO BE SOLVED: To provide a method for suppressing non-specific nucleic acid amplification in an RT-RamDA reaction.SOLUTION: The present invention provides a ...


Japan Intellectual Property Rights: METHOD FOR SUPPRESSING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION

Japan, Feb. 27 -- TOYOBO CO LTD,INSTITUTE OF PHYSICAL & CHEMICAL RESEARCH has got intellectual property rights for 'METHOD FOR SUPPRESSING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION.' Other related details are as follows: Application Number: JP,2019-176436 Category (FI): C12Q1/6876@Z,C12N15/09@Z,C12Q1/6844@Z,C12N9/22,C12N9/12 Stage: PROBLEM TO BE SOLVED: To provide a method for suppressing non-specific nucleic acid amplification in an RT-RamDA reaction.SOLUTION: The present invention provides a ...


Japan Intellectual Property Rights: SYSTEMS AND METHODS FOR REMOTELY PROCESSING DATA COLLECTED BY DRUG DELIVERY DEVICE

Japan, Feb. 27 -- AMGEN has got intellectual property rights for 'SYSTEMS AND METHODS FOR REMOTELY PROCESSING DATA COLLECTED BY DRUG DELIVERY DEVICE.' Other related details are as follows: Application Number: JP,2020-178668 Category (FI): A61M5/00,500 Stage: PROBLEM TO BE SOLVED: To provide systems and methods for processing sensor data collected by a drug delivery device with an external computing device.SOLUTION: A drug delivery device 302 includes a reservoir 312 and a delivery cannula hav...


Japan Intellectual Property Rights: SYSTEMS AND METHODS FOR REMOTELY PROCESSING DATA COLLECTED BY DRUG DELIVERY DEVICE

Japan, Feb. 27 -- AMGEN has got intellectual property rights for 'SYSTEMS AND METHODS FOR REMOTELY PROCESSING DATA COLLECTED BY DRUG DELIVERY DEVICE.' Other related details are as follows: Application Number: JP,2020-178668 Category (FI): A61M5/00,500 Stage: PROBLEM TO BE SOLVED: To provide systems and methods for processing sensor data collected by a drug delivery device with an external computing device.SOLUTION: A drug delivery device 302 includes a reservoir 312 and a delivery cannula hav...


Clinical Trial: A study to verify the suppressive effect of the test food on postprandial blood glucose elevation: a randomized, placebo-controlled, double-blind, crossover comparison study (Japan)

Tokyo, Feb. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060773) titled 'A study to verify the suppressive effect of the test food on postprandial blood glucose elevation: a randomized, placebo-controlled, double-blind, crossover comparison study' on Feb. 27. Study Type: Interventional Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Insti...


Clinical Trial: Effects of a stretching intervention on blood pressures in middle-aged and older adults (Japan)

Tokyo, Feb. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060778) titled 'Effects of a stretching intervention on blood pressures in middle-aged and older adults' on Feb. 27. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - No treatment Primary Sponsor: Institute - Ritsumeikan University Condition: Condition - Middle-aged and older men and wome...


Clinical Trial: A study to verify the effects of nomimamori gummy on promoting alcohol metabolism and removing acetaldehyde: an open-label study (Japan)

Tokyo, Feb. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060774) titled 'A study to verify the effects of nomimamori gummy on promoting alcohol metabolism and removing acetaldehyde: an open-label study' on Feb. 27. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control Primary Sponsor: Institute - National university corporation Tokushima Un...


Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Cranberry Extract on the Urinary Microbiome in Children with Nocturnal Enuresis (Japan)

Tokyo, Feb. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060777) titled 'KMU Cranberry On Nocturnal Enuresis for Continence Trial' on Feb. 27. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - Kansai Medical University Condition: Condition - Nocturnal enuresis Classification by malignancy - Others Genom...


Clinical Trial: Study on the Effects of Test Food Intake on Cognitive Function --A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Comparative Trial-- (Japan)

Tokyo, Feb. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060771) titled 'Study on the Effects of Test Food Intake on Cognitive Function --A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Comparative Trial--' on Feb. 27. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - TES Holdings Co., Ltd...


Clinical Trial: Post Marketing Survey of Healthcare Professionals Using a Viscosity Adjustable High Calorie Formula (Japan)

Tokyo, Feb. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060769) titled 'Post Marketing Survey of Healthcare Professionals Using a Viscosity Adjustable High Calorie Formula' on Feb. 27. Study Type: Observational Primary Sponsor: Institute - Nestle Health Science Company, Nestle Japan Ltd. Condition: Condition - Gastroesophageal reflux Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - This stu...